ft 10 sep 93 intern compani news us group alzheim drug win approv us food drug administr announc yesterday given warner lambert us pharmaceut concern final clearanc market cognex first drug specif approv us treatment alzheim diseas drug develop compani park davi divis could gener annual revenu dollar 400m dollar 500m within year accord estim oppenheim new york brokerag hous warner lambert declin comment project sale said cognex treatment would cost patient dollar 3 50 day govern approv expect cognex receiv favour recommend fda advisori committe march turn twice panel 1991 even warner lambert share rose sharpli yesterday afternoon close dollar 1 7 8 higher dollar 69 1 8 drug found effect eas symptom patient mild moder stage alzheim ill characteris progress declin memori judgment abil reason evid cognex alter cours underli dementia process estim 4m american afflict diseas compani estim 50 70 per cent could benefit cognex treatment fda last night call new test smithklin beecham ulcer drug tagamet uk pharmaceut group hope receiv approv sell best sell product counter us treatment heartburn write peter john london drug approv potenti boost compani sale estim dollar 200m dollar 300m year